Literature DB >> 1475177

Stability and compatibility of four anthracyclines: doxorubicin, epirubicin, daunorubicin and pirarubicin with PVC infusion bags.

T Dine1, J C Cazin, B Gressier, M Luyckx, C Brunet, M Cazin, F Goudaliez, M L Mallevais, I Toraub.   

Abstract

A rapid isocratic technique was developed for the analysis of four anthracyclines (doxorubicin, epirubicin, daunorubicin and pirarubicin) in parenteral solutions using high pressure liquid chromatography (HPLC) with fluorescence detection and a C18 Hypersil ODS column. The availability and compatibility of these drugs from solutions infused via PVC infusion bags through PVC administration sets have been examined. No significant drug loss was observed during simulated infusions (n = 4) for 24 h using PVC infusion bags and administration sets. No significant difference was found between infusion solutions (5% glucose or 0.9% NaCl), except for pirarubicin. The reconstitution of pirarubicin in 0.9% NaCl was impossible, because we observed a precipitation of the compound in solution. The stability of the drugs was also studied in solution, in PVC bags after storage at 4 degrees C with protection from light. The results show the stability of doxorubicin, epirubicin and daunorubicin during 7 days of storage to be satisfactory, irrespective of the infusion solution (5% glucose or 0.9% NaCl). In the case of pirarubicin, the stability of the drug was satisfactory during 5 days of storage in 5% glucose, but beyond, we observed a degradation of the compound with formation of doxorubicin in the infusion solution.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1475177     DOI: 10.1007/bf01970174

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  17 in total

Review 1.  Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. II. Assay methods, adriamycin and the other antitumour antibiotics.

Authors:  A G Bosanquet
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  Phase II study of a 21-day continuous infusion schedule with epirubicin in metastatic colorectal cancer.

Authors:  J Greidanus; P H Willemse; D T Sleijfer; N H Mulder; R C Verschueren; R Nieweg; E G de Vries
Journal:  Eur J Cancer Clin Oncol       Date:  1988-04

3.  Interactions between drugs and plastic intravenous fluid bags. I. Sorption studies on 17 drugs.

Authors:  P Moorhatch; W L Chiou
Journal:  Am J Hosp Pharm       Date:  1974-01

Review 4.  Continuous infusion of low-dose doxorubicin, epirubicin and mitoxantrone in cancer chemotherapy: a review.

Authors:  J Greidanus; P H Willemse; D R Uges; E T Oremus; Z J De Langen; E G De Vries
Journal:  Pharm Weekbl Sci       Date:  1988-12-09

Review 5.  Continuous infusion or bolus injection in cancer chemotherapy.

Authors:  R W Carlson; B I Sikic
Journal:  Ann Intern Med       Date:  1983-12       Impact factor: 25.391

6.  [Structure and activity of anthracyclines].

Authors:  F Lavelle
Journal:  Pathol Biol (Paris)       Date:  1987-01

7.  Increasing the accumulation of daunorubicin in human leukemic cells by prolonging the infusion time.

Authors:  C Paul; U Tidefelt; J Liliemark; C Peterson
Journal:  Leuk Res       Date:  1989       Impact factor: 3.156

8.  [Pharmacokinetics of pirarubicin (THP-doxorubicin) in patients with cancer].

Authors:  J Robert; M David; S Huet; J Chauvergne; A Monnier
Journal:  Bull Cancer       Date:  1989       Impact factor: 1.276

9.  Cellular and plasma adriamycin concentrations in long-term infusion therapy of leukemia patients.

Authors:  P A Speth; P C Linssen; J B Boezeman; H M Wessels; C Haanen
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

10.  Leukemic cell and plasma daunomycin concentrations after bolus injection and 72 h infusion.

Authors:  P A Speth; P C Linssen; J B Boezeman; H M Wessels; C Haanen
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.